We narrowed to 357 results for: flpo
-
Plasmid#72262PurposeExpress FLPe under EF-1 promoterDepositorInsertFLPe
UseLentiviralExpressionMammalianPromoterelongation factor-1Available SinceJan. 11, 2016AvailabilityIndustry, Academic Institutions, and Nonprofits -
pGC92
Plasmid#19615DepositorInsertFLP
UseCarries flp recombinase cdnaAvailable SinceFeb. 23, 2009AvailabilityAcademic Institutions and Nonprofits only -
AiP14573: pAAV-AiE0452h-minBG-FlpO-WPRE3-BGHpA (Alias: CN4573)
Plasmid#230871PurposeAiE0452h is an enhancer sequence, designed to drive AAV-mediated transgene expression in striatal indirect pathway MSNs (D2-MSNs)DepositorInsertFlpO
UseAAVExpressionMammalianAvailable SinceJan. 29, 2025AvailabilityAcademic Institutions and Nonprofits only -
pJH2673
Plasmid#199691PurposePnmr-1 FLPe unc-54 3' UTR C.elegans AVA/E/D premotor IN and others expression of FLPeDepositorAvailable SinceMay 7, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
pAT03-Apr
Plasmid#154756PurposeFor curing of the resistance marker of RecET recombinase system in Acinetobacter baumannii, AprarDepositorInsertFLP recombinase
ExpressionBacterialAvailable SinceAug. 24, 2020AvailabilityAcademic Institutions and Nonprofits only -
AAV phSyn1(S)-FlpO-bGHpA (AAV Retrograde)
Viral Prep#51669-AAVrgPurposeReady-to-use AAV Retrograde particles produced from AAV phSyn1(S)-FlpO-bGHpA (#51669). In addition to the viral particles, you will also receive purified AAV phSyn1(S)-FlpO-bGHpA plasmid DNA. hSyn-driven FlpO expression. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynAvailable SinceOct. 28, 2021AvailabilityAcademic Institutions and Nonprofits only -
AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV9)
Viral Prep#87306-AAV9PurposeReady-to-use AAV9 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aAvailable SinceJan. 26, 2021AvailabilityAcademic Institutions and Nonprofits only -
AAV phSyn1(S)-FlpE-bGHpA
Plasmid#50364PurposeCan be used to generate AAV virus that will express FlpE recombinse gene in neurons from the synapsin promoterDepositorInsertFlpE recombinase gene
UseAAVPromoterhSyn1Available SinceJan. 16, 2014AvailabilityAcademic Institutions and Nonprofits only -
pCSHSP:FLP
Plasmid#30521DepositorInsertFLP recombinase
UseFlp/frtExpressionMammalianAvailable SinceOct. 14, 2011AvailabilityAcademic Institutions and Nonprofits only -
AiP1635 - pAAV-AiE2116m-minBG-FlpO-WPRE-BGHpA
Plasmid#230680PurposeAiE2116m is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cellsDepositorInsertFlpO
UseAAVPromoterminBGAvailable SinceMarch 24, 2025AvailabilityAcademic Institutions and Nonprofits only -
pSADdeltaG-FLPo-DsRedX
Plasmid#32650DepositorInsertsFLPo
DsRedX
UseRabies virusExpressionMammalianPromoterCMVAvailable SinceOct. 18, 2011AvailabilityAcademic Institutions and Nonprofits only -
pAAV-EF1a-mCherry-IRES-Flpo (AAV1)
Viral Prep#55634-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-EF1a-mCherry-IRES-Flpo (#55634). In addition to the viral particles, you will also receive purified pAAV-EF1a-mCherry-IRES-Flpo plasmid DNA. EF1a-driven mCherry and bicistronic Flp recombinase expression. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1a and Ef1a/IRESTagsmCherryAvailable SinceMay 31, 2019AvailabilityAcademic Institutions and Nonprofits only -
pCMVTnT-Flp-3xFLAG
Plasmid#109167PurposeEncodes yeast full-length Flp with C-terminal 3xFLAG tag to be expressed in a mammalian expression systemDepositorInsertFlp
Tags3xFLAGExpressionMammalianPromoterCMVAvailable SinceJan. 25, 2019AvailabilityAcademic Institutions and Nonprofits only -
pCAGGS-pac-T2A-FLPo
Plasmid#124835PurposePuromycin resistance gene and FLP recombinaseDepositorInsertpac-T2A-FLPo
ExpressionMammalianAvailable SinceJune 19, 2019AvailabilityAcademic Institutions and Nonprofits only -
AiP1233 - pAAV-AiE0128h-minBG-FlpO-WPRE-HGHpA (Alias: CN233)
Plasmid#230204PurposeAiE0128h is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cellsDepositorInsertFlpO
UseAAVPromoterminBGAvailable SinceAug. 19, 2025AvailabilityAcademic Institutions and Nonprofits only -
AiP1231 - pAAV-AiE0082h-minBG-FlpO-WPRE-HGHpA (Alias: CN231)
Plasmid#230200PurposeAiE0082h is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cellsDepositorInsertFlpO
UseAAVPromoterminBGAvailable SinceAug. 19, 2025AvailabilityAcademic Institutions and Nonprofits only -
AiP12783 - pAAV-AiE0330h-minBG-FlpO-WPRE3-HGHpA (Alias: CN2783)
Plasmid#230439PurposeAiE0330h is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cellsDepositorInsertFlpO
UseAAVPromoterminBGAvailable SinceMay 30, 2025AvailabilityAcademic Institutions and Nonprofits only -
AiP1217 - pAAV-AiE2056m-minBG-FlpO-WPRE-HGHpA
Plasmid#230591PurposeAiE2056m is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cellsDepositorInsertFlpO
UseAAVPromoterminBGAvailable SinceMay 8, 2025AvailabilityAcademic Institutions and Nonprofits only -
AiP1214 - pAAV-AiE2054m-minBG-FlpO-WPRE-HGHpA
Plasmid#230588PurposeAiE2054m is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cellsDepositorInsertFlpO
UseAAVPromoterminBGAvailable SinceMay 8, 2025AvailabilityAcademic Institutions and Nonprofits only -
AiP1191 - pAAV-AiE2047m-minBG-FlpO-WPRE-HGHpA
Plasmid#230582PurposeAiE2047m is an enhancer sequence, designed to drive AAV-mediated transgene expression in specific populations of brain cellsDepositorInsertFlpO
UseAAVPromoterminBGAvailable SinceMay 8, 2025AvailabilityAcademic Institutions and Nonprofits only